Eli Lilly drug tirzepatide meets weight-loss goals in obesity trial
A highly anticipated clinical trial from Eli Lilly showed its Type 2 diabetes drug met its primary endpoints. CNBC’s Meg Tirrell joins ‘Squawk Box’ to break down the results.
Read More »
Wedbush’s Joel Kulina: Microsoft, Apple remain last safe havens of the market
Joel Kulina, Head of Technology/Media Trading at Wedbush Securities, joins Worldwide Exchange to discuss the tech sector outlook ahead of the anticipated Big Tech earnings reports later today.
Read More »
Matt Orton: Information technology, healthcare are areas of interest
Matt Orton of Carillon Tower Advisers joins Worldwide Exchange to give his take on what’s driving the market.
Read More »
Crypto prices rebound and Solana’s co-founder thinks bitcoin needs proof of stake: CNBC Crypto World
CNBC Crypto World features the latest news and daily trading updates from the digital currency markets and provides viewers with a look at what’s ahead with high-profile interviews, explainers, and unique stories from the ever-changing crypto industry. On today’s show,…
Read More »
Jim Cramer: Mark Zuckerberg is working on the ‘omniverse,’ I’d like him to work on Instagram
Mad Money host Jim Cramer joins the ‘Halftime Report’ to look ahead to Meta earnings and discusses what he’d like to see CEO Mark Zuckerberg do for the company. For access to live and exclusive video from CNBC subscribe to…
Read More »
‘Halftime Report’ Unusual Activity: XLE and Valero
“Halftime Report” trader Pete Najarian spots unusual activity in the options market. For access to live and exclusive video from CNBC subscribe to CNBC PRO: » Subscribe to CNBC TV: » Subscribe to CNBC: Turn to CNBC TV for the…
Read More »
Final Trades: Northrop Grumman, American Express, BHP & more
The “Halftime Report” traders give their top picks to watch for the second half.
Read More »
This is Halliburton’s time, says Mad Money host Jim Cramer
Mad Money host Jim Cramer joins the ‘Halftime Report’ to discuss his feelings about oil and oil stocks.
Read More »